22.418 articles found

Outcome prediction of enteral levodopa/carbidopa infusion in advanced Parkinson's disease.

Westin J, Nyholm D, Groth T, Dougherty MS, Yerramsetty PK, Palhagen SE.

Parkinsonism Relat Disord · 2006-05-30

DOI: 10.1016/j.parkreldis.2006.02.006PMID: 16731025

TREATMENT OF PROTEIN FOLDING DISORDERS

CARTER MICHAEL D, HADDEN MARK, WEAVER DONALD F, JACOBO SHEILA MARIE H, LU ERHU.

· 2006-05-29

TREATMENT OF PROTEIN FOLDING DISORDERS

HADDEN MARK, CARTER MICHAEL D, LU ERHU, JACOBO SHEILA MARIE H, WEAVER DONALD F.

· 2006-05-29

A METHOD FOR THE PREVENTION AND/OR TREATMENT OF NEURODEGENERATIVE DISEASES CHARACTERIZED BY ADMINISTERING AN EP1 RECEPTOR ANTAGONIST

DORE Sylvain.

· 2006-05-25

Method for the Prevention and/or Treatment of Neurodegenerative Diseases Characterized by Administering and Ep1 Receptor Antagonist

DORE SYLVAIN.

· 2006-05-25

Repeated l-DOPA treatment increases c-fos and BDNF mRNAs in the subthalamic nucleus in the 6-OHDA rat model of Parkinson's disease.

Zhang X, Andren PE, Svenningsson P.

Brain Res · 2006-05-24

DOI: 10.1016/j.brainres.2006.04.019PMID: 16725125

Dopamine agonist therapy for Parkinson disease and pathological gambling.

Imamura A, Uitti RJ, Wszolek ZK.

Parkinsonism Relat Disord · 2006-05-24

DOI: 10.1016/j.parkreldis.2006.02.004PMID: 16723269

Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease.

Bonsi P, Cuomo D, Picconi B, Sciamanna G, Tscherter A, Tolu M, Bernardi G, Calabresi P, Pisani A.

Amino Acids · 2006-05-22

DOI: 10.1007/s00726-006-0320-3PMID: 16715415

AGENT FOR NEUROPROTECTION OR FOR PROPHYLAXIS OR TREATMENT OF NEURODEGENERATIVE DISORDERS CONTAINING METHANOL EXTRACT OF SMILACIS CHINAE RHIZOME

SEONG YEON HEE, SONG KYUNG SIK, BAN JU YEON, JEONG HYUN HEE, SEONG NAK SUL.

· 2006-05-19

COMPOSITION AND DOSAGE FORM FOR SUSTAINED EFFECT OF LEVODOPA

FLASHNER BARAK MOSHE, LERNER E ITZHAK, ROSENBERGER VERED.

· 2006-05-19

Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease

DIETER SCHELLER, FRANK DRESSEN.

· 2006-05-19

Unilateral intraputaminal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year each of treatment and withdrawal.

Slevin JT, Gash DM, Smith CD, Gerhardt GA, Kryscio R, Chebrolu H, Walton A, Wagner R, Young AB.

Neurosurg Focus · 2006-05-15

DOI: 10.3171/foc.2006.20.5.2PMID: 16711657